EP3146077A4 - Signatures moléculaires de tissu de rejets de transplantation hépatique - Google Patents

Signatures moléculaires de tissu de rejets de transplantation hépatique Download PDF

Info

Publication number
EP3146077A4
EP3146077A4 EP15795618.6A EP15795618A EP3146077A4 EP 3146077 A4 EP3146077 A4 EP 3146077A4 EP 15795618 A EP15795618 A EP 15795618A EP 3146077 A4 EP3146077 A4 EP 3146077A4
Authority
EP
European Patent Office
Prior art keywords
kidney transplant
molecular signatures
transplant rejections
tissue molecular
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
EP15795618.6A
Other languages
German (de)
English (en)
Other versions
EP3146077A1 (fr
Inventor
Daniel Salomon
Sunil KURIAN
Michael Abecassis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Northwestern University
Original Assignee
Scripps Research Institute
Northwestern University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2014/054735 external-priority patent/WO2015035367A1/fr
Application filed by Scripps Research Institute, Northwestern University filed Critical Scripps Research Institute
Priority to EP20193121.9A priority Critical patent/EP3825417A3/fr
Publication of EP3146077A1 publication Critical patent/EP3146077A1/fr
Publication of EP3146077A4 publication Critical patent/EP3146077A4/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G01N2800/245—Transplantation related diseases, e.g. graft versus host disease

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP15795618.6A 2014-05-22 2015-05-22 Signatures moléculaires de tissu de rejets de transplantation hépatique Ceased EP3146077A4 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP20193121.9A EP3825417A3 (fr) 2014-05-22 2015-05-22 Signatures moléculaires de tissu de rejets de transplantation hépatique

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201462001902P 2014-05-22 2014-05-22
US201462001909P 2014-05-22 2014-05-22
US201462001889P 2014-05-22 2014-05-22
US201462029038P 2014-07-25 2014-07-25
PCT/US2014/054735 WO2015035367A1 (fr) 2013-09-09 2014-09-09 Méthodes et systèmes permettant l'analyse d'une transplantation d'organes
US14/481,167 US20150167085A1 (en) 2013-09-09 2014-09-09 Methods and Systems for Analysis of Organ Transplantation
PCT/US2015/032195 WO2015179773A1 (fr) 2014-05-22 2015-05-22 Signatures moléculaires de tissu de rejets de transplantation hépatique

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP20193121.9A Division EP3825417A3 (fr) 2014-05-22 2015-05-22 Signatures moléculaires de tissu de rejets de transplantation hépatique

Publications (2)

Publication Number Publication Date
EP3146077A1 EP3146077A1 (fr) 2017-03-29
EP3146077A4 true EP3146077A4 (fr) 2018-05-02

Family

ID=63013167

Family Applications (2)

Application Number Title Priority Date Filing Date
EP15795618.6A Ceased EP3146077A4 (fr) 2014-05-22 2015-05-22 Signatures moléculaires de tissu de rejets de transplantation hépatique
EP20193121.9A Pending EP3825417A3 (fr) 2014-05-22 2015-05-22 Signatures moléculaires de tissu de rejets de transplantation hépatique

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP20193121.9A Pending EP3825417A3 (fr) 2014-05-22 2015-05-22 Signatures moléculaires de tissu de rejets de transplantation hépatique

Country Status (2)

Country Link
EP (2) EP3146077A4 (fr)
WO (1) WO2015179773A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014182330A1 (fr) 2013-05-06 2014-11-13 Hitachi Chemical Company Ltd Dispositifs et procédés de capture de molécules-cibles
US11104951B2 (en) 2014-05-22 2021-08-31 The Scripps Research Institute Molecular signatures for distinguishing liver transplant rejections or injuries
WO2017040515A1 (fr) * 2015-08-31 2017-03-09 Hitachi Chemical Co., Ltd. Méthodes moléculaires pour évaluer des complications post-greffe rénale
JP6624704B2 (ja) 2015-08-31 2019-12-25 日立化成株式会社 尿路上皮疾患の評価のための分子法
WO2019050478A1 (fr) * 2017-09-05 2019-03-14 Agency For Science, Technology And Research Biomarqueurs du carcinome à cellules rénales à cellules claires
US20220081715A1 (en) 2019-01-17 2022-03-17 Katholieke Universiteit Leuven mRNA-BASED BIOMARKERS FOR ANTIBODY-MEDIATED TRANSPLANT REJECTION
WO2026036182A1 (fr) * 2024-08-15 2026-02-19 The Westmead Institute for Medical Research Biomarqueurs et leurs utilisations

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130040301A1 (en) * 1997-09-24 2013-02-14 Cornell Research Foundation, Inc. Methods of Evaluating Transplant Rejection

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US6040138A (en) 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
US5210015A (en) 1990-08-06 1993-05-11 Hoffman-La Roche Inc. Homogeneous assay system using the nuclease activity of a nucleic acid polymerase
CA2072758A1 (fr) 1990-09-14 1992-03-15 Kenneth Francis Buechler Anticorps liant aux complexes de recepteurs de ligands et de ligands et leur utilite dans les tests ligand-recepteur
AU1772992A (en) 1991-04-10 1992-11-17 Biosite Diagnostics Incorporated Crosstalk inhibitors and their uses
EP0579767B1 (fr) 1991-04-11 2000-08-23 Biosite Diagnostics Inc. Nouveaux conjugues et dosages destines a la detection simultanee de ligands multiples
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US5458852A (en) 1992-05-21 1995-10-17 Biosite Diagnostics, Inc. Diagnostic devices for the controlled movement of reagents without membranes
US6019944A (en) 1992-05-21 2000-02-01 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membranes
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US5538848A (en) 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
US5631734A (en) 1994-02-10 1997-05-20 Affymetrix, Inc. Method and apparatus for detection of fluorescently labeled materials
US5578832A (en) 1994-09-02 1996-11-26 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
WO1997027317A1 (fr) 1996-01-23 1997-07-31 Affymetrix, Inc. Evaluation rapide de difference d'abondance d'acides nucleiques, avec un systeme d'oligonucleotides haute densite
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US5863736A (en) 1997-05-23 1999-01-26 Becton, Dickinson And Company Method, apparatus and computer program products for determining quantities of nucleic acid sequences in samples
US6453242B1 (en) 1999-01-12 2002-09-17 Sangamo Biosciences, Inc. Selection of sites for targeting by zinc finger proteins and methods of designing zinc finger proteins to bind to preselected sites
CN1253449C (zh) 2000-11-07 2006-04-26 诺瓦提斯公司 作为蛋白激酶c抑制剂的吲哚基马来酰亚胺衍生物
US20040126767A1 (en) 2002-12-27 2004-07-01 Biosite Incorporated Method and system for disease detection using marker combinations
AR039209A1 (es) 2002-04-03 2005-02-09 Novartis Ag Derivados de indolilmaleimida
KR20050084224A (ko) 2002-12-09 2005-08-26 더 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 야누스 티로신 키나제 3을 선택적으로 저해하는 방법
JP2006526140A (ja) 2002-12-24 2006-11-16 バイオサイト インコーポレイテッド 鑑別診断のためのマーカーおよびその使用方法
ES2389203T3 (es) 2004-01-12 2012-10-24 Ym Biosciences Australia Pty Ltd Inhibidores de quinasa selectivos
GB0605217D0 (en) 2006-03-15 2006-04-26 Novartis Ag Method and compositions for assessing acute rejection
EP2076614A4 (fr) 2006-10-16 2012-07-04 Univ Arizona Anticorps synthetiques
JP2011515068A (ja) 2007-11-08 2011-05-19 ノバルティス アーゲー 慢性／硬化性同種移植腎症に対する遺伝子発現シグネチャー
US20110003708A1 (en) * 2007-12-27 2011-01-06 Compugen Ltd. Biomarkers for the prediction of renal injury
WO2012031008A2 (fr) * 2010-08-31 2012-03-08 The General Hospital Corporation Matières biologiques liées au cancer dans des microvésicules

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130040301A1 (en) * 1997-09-24 2013-02-14 Cornell Research Foundation, Inc. Methods of Evaluating Transplant Rejection

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANDREAS SCHERER ET AL: "Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months", NEPHROLOGY DIALYSIS TRANSPLANTATION., vol. 24, no. 8, August 2009 (2009-08-01), GB, pages 2567 - 2575, XP055432051, ISSN: 0931-0509, DOI: 10.1093/ndt/gfp183 *
FLECHNER S M ET AL: "Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes", AMERICAN JOURNAL OF TRANSPLANTATION, BLACKWELL MUNKSGAARD, DK, vol. 4, no. 9, September 2004 (2004-09-01), pages 1475 - 1489, XP008103279, ISSN: 1600-6135, [retrieved on 20040607], DOI: 10.1111/J.1600-6143.2004.00526.X *
J. L. GOULET ET AL: "Deficiency of 5-Lipoxygenase Accelerates Renal Allograft Rejection in Mice", THE JOURNAL OF IMMUNOLOGY, vol. 167, no. 11, December 2001 (2001-12-01), US, pages 6631 - 6636, XP055432046, ISSN: 0022-1767, DOI: 10.4049/jimmunol.167.11.6631 *
NILS HEYNE ET AL: "Urinary Neutrophil Gelatinase-Associated Lipocalin Accurately Detects Acute Allograft Rejection Among Other Causes of Acute Kidney Injury in Renal Allograft Recipients", TRANSPLANTATION, vol. 93, no. 12, June 2012 (2012-06-01), GB, pages 1252 - 1257, XP055357590, ISSN: 0041-1337, DOI: 10.1097/TP.0b013e31824fd892 *
S. M. KURIAN ET AL: "Molecular Classifiers for Acute Kidney Transplant Rejection in Peripheral Blood by Whole Genome Gene Expression Profiling", AMERICAN JOURNAL OF TRANSPLANTATION, vol. 14, no. 5, 11 April 2014 (2014-04-11), pages 1164 - 1172, XP055172952, ISSN: 1600-6135, DOI: 10.1111/ajt.12671 *
See also references of WO2015179773A1 *

Also Published As

Publication number Publication date
EP3825417A2 (fr) 2021-05-26
WO2015179773A1 (fr) 2015-11-26
EP3146077A1 (fr) 2017-03-29
EP3825417A3 (fr) 2021-09-15

Similar Documents

Publication Publication Date Title
EP3127357B8 (fr) Système de vie
EP3136995A4 (fr) Dispositif chirurgical de saisie
EP3178411A4 (fr) Instrument chirurgical
EP3123948A4 (fr) Instrument chirurgical
EP3072436A4 (fr) Endoscope
EP3203924A4 (fr) Système chirurgical électromécanique
EP3213692A4 (fr) Instrument chirurgical
EP3167816A4 (fr) Agrafeuse linéaire chirurgicale
EP3097843A4 (fr) Endoscope
EP3047788A4 (fr) Endoscope
EP3122261A4 (fr) Appareil d'agrafage chirurgical
EP3166590A4 (fr) Dispositif de réduction de l'apparence des pores
EP3050488A4 (fr) Endoscope
EP3166979A4 (fr) Ultrafiltration de copolymères de poly(isooléfine)
EP3178410A4 (fr) Instrument chirurgical
EP3175768A4 (fr) Endoscope
EP3189413A4 (fr) Pile de cartes
EP3227276A4 (fr) Combinaisons pour le traitement du neuroblastome
EP3195842A4 (fr) Table chirurgicale
EP3205253A4 (fr) Endoscope
EP3138467A4 (fr) Endoscope
EP3152579A4 (fr) Mammographie moléculaire
EP3231347A4 (fr) Endoscope
EP3158912A4 (fr) Endoscope
EP3239292A4 (fr) Fluide de surnageant de culture de cellules dérivé de tissu pulmonaire

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20161124

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/68 20060101ALI20171213BHEP

Ipc: G01N 33/53 20060101ALI20171213BHEP

Ipc: C12Q 1/68 20180101AFI20171213BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20180405

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/53 20060101ALI20180329BHEP

Ipc: G01N 33/68 20060101ALI20180329BHEP

Ipc: C12Q 1/68 20060101AFI20180329BHEP

17Q First examination report despatched

Effective date: 20190502

REG Reference to a national code

Ref country code: DE

Ref legal event code: R003

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN REFUSED

18R Application refused

Effective date: 20201025